Arhalofenate acid inhibits monosodium urate crystal-induced inflammatory responses through activation of AMP-activated protein kinase (AMPK) signaling

Autor: Sushil K. Mahata, Ramon L. Serrano, Ru Liu-Bryan, Charles McWherter, Robert Terkeltaub, Yun-Jung Choi
Rok vydání: 2018
Předmět:
0301 basic medicine
AMPK
lcsh:Diseases of the musculoskeletal system
Gout
Mitochondrion
AMP-Activated Protein Kinases
medicine.disease_cause
Inbred C57BL
Mice
AMP-activated protein kinase
Acetamides
2.1 Biological and endogenous factors
Autophagy flux
Aetiology
Receptor
Cells
Cultured

Phenylacetates
Cultured
biology
Chemistry
3. Good health
Mitochondria
5.1 Pharmaceuticals
Public Health and Health Services
Phosphorylation
Inflammation Mediators
Development of treatments and therapeutic interventions
Research Article
Signal Transduction
Cells
Clinical Sciences
Immunology
Bone Marrow Cells
03 medical and health sciences
medicine
Animals
Protein kinase A
Inflammation
Arthritis
Inflammatory and immune system
Autophagy
Molecular biology
Uric Acid
Arthritis & Rheumatology
Mice
Inbred C57BL

030104 developmental biology
biology.protein
lcsh:RC925-935
Oxidative stress
Zdroj: Arthritis research & therapy, vol 20, iss 1
Arthritis Research & Therapy
Arthritis Research & Therapy, Vol 20, Iss 1, Pp 1-11 (2018)
Popis: Background Arhalofenate acid, the active acid form of arhalofenate, is a non-agonist peroxisome proliferator-activated receptor γ (PPARγ) ligand, with uricosuric activity via URAT1 inhibition. Phase II studies revealed decreased acute arthritis flares in arhalofenate-treated gout compared with allopurinol alone. Hence, we investigated the anti-inflammatory effects and mechanisms of arhalofenate and its active acid form for responses to monosodium urate (MSU) crystals. Methods We assessed in-vivo responses to MSU crystals in murine subcutaneous air pouches and in-vitro responses in murine bone marrow-derived macrophages (BMDMs) by enzyme-linked immunosorbent assay (ELISA), SDS-PAGE/Western blot, immunostaining, and transmission electron microscopy analyses. Results Oral administration of arhalofenate (250 mg/kg) blunted total leukocyte ingress, neutrophil influx, and air pouch fluid interleukin (IL)-1β, IL-6, and CXCL1 in response to MSU crystal injection (p
Databáze: OpenAIRE